PepGen (PEPG) Tax Provisions (2022 - 2026)

PepGen (PEPG) reported Tax Provisions of $15000.0 for Q1 2026, up 102.08% sequentially from -$720000.0 in Q4 2022.

PepGen (PEPG) Tax Provisions (2022 - 2026) Analysis & Trends

PepGen (PEPG) has 2 years of Tax Provisions data on file, last reported at $15000.0 in Q1 2026.

For the quarter ending Q1 2026, Tax Provisions changed N/A year-over-year to $15000.0; the trailing twelve-month figure through Mar 2026 stood at -$685000.0 (up 4.86% YoY), and the FY2025 full-year result was $49000.0, up 107.94% from the prior year.
Tax Provisions rose to $15000.0 in Q1 2026, from -$720000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $4.4 million in Q1 2022 to a low of -$720000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	125,146.46
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	31.86 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	179.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	PepGen	145.09 Mn	145.09 Mn	-	15,000.00

Download Data